BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 10377791)

  • 1. [Infection and multiple sclerosis].
    Yamamura T
    Rinsho Shinkeigaku; 1999 Jan; 39(1):24-5. PubMed ID: 10377791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of experimental autoimmune encephalomyelitis in Lewis rats by a viral peptide with limited homology to myelin basic protein.
    Mao YS; Lu CZ; Wang X; Xiao BG
    Exp Neurol; 2007 Aug; 206(2):231-9. PubMed ID: 17617406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of myelin reactive T cells in multiple sclerosis: a possible role for T cell degeneracy?
    Stinissen P; Hellings N
    Eur J Immunol; 2008 May; 38(5):1190-3. PubMed ID: 18425726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of molecular mimicry.
    Wucherpfennig KW
    J Autoimmun; 2001 May; 16(3):293-302. PubMed ID: 11334495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA-based vaccines: the future of multiple sclerosis therapy?
    Stüve O; Cravens PD; Eagar TN
    Expert Rev Neurother; 2008 Mar; 8(3):351-60. PubMed ID: 18345967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis.
    Tejada-Simon MV; Zang YC; Hong J; Rivera VM; Zhang JZ
    Ann Neurol; 2003 Feb; 53(2):189-97. PubMed ID: 12557285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degenerate T-cell receptor recognition, autoreactive cells, and the autoimmune response in multiple sclerosis.
    Markovic-Plese S
    Neuroscientist; 2009 Jun; 15(3):225-31. PubMed ID: 19297658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
    Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
    Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate and adaptive immune requirements for induction of autoimmune demyelinating disease by molecular mimicry.
    Olson JK; Ludovic Croxford J; Miller SD
    Mol Immunol; 2004 Feb; 40(14-15):1103-8. PubMed ID: 15036915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Activation of T cells in experimental autoimmune encephalomyelitis and multiple sclerosis].
    Rodríguez-Rodríguez Y; Suárez-Luis I
    Rev Neurol; 2003 Apr 1-15; 36(7):649-52. PubMed ID: 12666047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell vaccination in multiple sclerosis.
    Achiron A; Mandel M
    Autoimmun Rev; 2004 Jan; 3(1):25-32. PubMed ID: 14871646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Th2 immune regulation induced by T cell vaccination in patients with multiple sclerosis.
    Zang YC; Hong J; Tejada-Simon MV; Li S; Rivera VM; Killian JM; Zhang JZ
    Eur J Immunol; 2000 Mar; 30(3):908-13. PubMed ID: 10741408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell vaccination in multiple sclerosis: immunoregulatory mechanism and prospects for therapy.
    Zhang J
    Crit Rev Immunol; 2001; 21(1-3):41-55. PubMed ID: 11642613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial toxin superantigens activate human T lymphocytes reactive with myelin autoantigens.
    Burns J; Littlefield K; Gill J; Trotter JL
    Ann Neurol; 1992 Sep; 32(3):352-7. PubMed ID: 1384422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of gender on T-cell proliferative responses to myelin proteolipid protein antigens in patients with multiple sclerosis and controls.
    Greer JM; Csurhes PA; Pender MP; McCombe PA
    J Autoimmun; 2004 Jun; 22(4):345-52. PubMed ID: 15120759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease.
    Fuller KG; Olson JK; Howard LM; Croxford JL; Miller SD
    Methods Mol Med; 2004; 102():339-61. PubMed ID: 15286394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunology of multiple sclerosis: disease mechanisms and therapeutic targets.
    Holmøy T
    Minerva Med; 2008 Apr; 99(2):119-40. PubMed ID: 18431322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell vaccination in multiple sclerosis: update on clinical application and mode of action.
    Hellings N; Raus J; Stinissen P
    Autoimmun Rev; 2004 Jun; 3(4):267-75. PubMed ID: 15246022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination.
    Hermans G; Denzer U; Lohse A; Raus J; Stinissen P
    J Autoimmun; 1999 Sep; 13(2):233-46. PubMed ID: 10479392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mimicry and antigen-specific T cell responses in multiple sclerosis and chronic CNS Lyme disease.
    Martin R; Gran B; Zhao Y; Markovic-Plese S; Bielekova B; Marques A; Sung MH; Hemmer B; Simon R; McFarland HF; Pinilla C
    J Autoimmun; 2001 May; 16(3):187-92. PubMed ID: 11334482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.